Kinnate Biopharma
(NASDAQ) KNTE
Kinnate Biopharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$110.94M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
KNTE News
KNTE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kinnate Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
27
CEO
Nima M. Farzan, MBA
Website
www.kinnate.comHeadquarters
San Francisco, CA 94129, US
KNTE Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-59%
Return on Capital
-74%
Return on Assets
-65%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$799.00K
Operating Income
$119.01M
EBITDA
$118.21M
Operating Cash Flow
$100.04M
Capital Expenditure
$0.00
Free Cash Flow
$100.04M
Cash & ST Invst.
$154.03M
Total Debt
$3.17M
Kinnate Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$198.00K
-4.2%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
84
N/A
Net Income
$17.06M
+43.0%
EBITDA
$18.91M
+38.8%
Quarterly Fundamentals
Net Cash
$150.86M
-23.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.28M
-28.5%
Short Term Debt
$892.00K
-10.0%
Return on Assets
-64.89%
N/A
Return on Invested Capital
-73.64%
N/A
Free Cash Flow
$17.36M
+27.2%
Operating Cash Flow
$17.36M
+26.9%